Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective Evaluation of Pre-empTive Left Atrial Venoarterial Extra-Corporeal Membrane oxygenaTion for Complex High-risk Transcatheter Aortic Valve Replacement: PROTECT-TAVR

NCT07309029 is registered in ClinicalTrials.gov with Atlantic Health System as lead sponsor.

NCT NCT07309029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07309029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective Evaluation of Pre-empTive Left Atrial Venoarterial Extra-Corporeal Membrane oxygenaTion for Complex High-risk Transcatheter Aortic Valve Replacement: PROTECT-TAVR
Lead sponsor
Atlantic Health System
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2026
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, cardiogenic shock, ecmo, severe aortic stenosis, trans-catheter aortic valve implantation